Oslo University Hospital

News and Video Search Results

News coverage

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

GlobeNewswire 25 Apr 2024

LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary..

Does Using Your Brain More At Work Help Ward Off Thinking, Memory Problems?
Eurasia Review 18 Apr 2024
Ultimovacs – Invitation to Business Update on April 17, 2024
GlobeNewswire 09 Apr 2024
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024
GlobeNewswire 04 Apr 2024
Building A Decent Gaza – Analysis
Eurasia Review 28 Mar 2024

0 shares 1 views

You might like

Oslo University Hospital media coverage

Nordea's Annual General Meeting 2024 and decisions of the statutory Board meeting

EQS Group 21 Mar 2024

Nordea Bank Abp / Key word(s): AGMEGM
Nordea's Annual General Meeting 2024 and decisions of the statutory Board..

Ultimovacs Announces Topline Results from INITIUM Study Evaluating UV1 Vaccination Added to Ipilimumab and Nivolumab in Patients with Unresectable or Metastatic Malignant Melanoma
GlobeNewswire 07 Mar 2024
Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer
GlobeNewswire 02 Mar 2024
Ultimovacs Receives EMA Orphan Drug Designation for UV1 Cancer Vaccine for the Treatment of Mesothelioma
GlobeNewswire 19 Feb 2024
National Security Multi-Mission Vessel (NSMV) Program Achieves Milestone with Steel Cutting of Fifth Ship
Accesswire 09 Feb 2024

Advertisement

More coverage

Ultimovacs Receives FDA Fast Track Designation for UV1 Cancer Vaccine for the Treatment of Patients with Unresectable Mesothelioma

GlobeNewswire 05 Feb 2024

· Fast Track designation is granted for UV1 in combination with ipilimumab and nivolumab for the treatment of patients with..